Cargando…

Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review

Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (NG), compromising gonorrhea treatment, is a global public health concern. Improved, quality-assured NG AMR monitoring at the global level is essential. This mini-review examined NG AMR susceptibility surveillance and AMR data from the African...

Descripción completa

Detalles Bibliográficos
Autores principales: Kakooza, Francis, Kiggundu, Reuben, Mboowa, Gerald, Kateete, Patrick David, Nsangi, Olga Tendo, Kabahita, Jupiter Marina, Ssentalo Bagaya, Bernard, Golparian, Daniel, Unemo, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117771/
https://www.ncbi.nlm.nih.gov/pubmed/37089569
http://dx.doi.org/10.3389/fmicb.2023.1148817
_version_ 1785028661881077760
author Kakooza, Francis
Kiggundu, Reuben
Mboowa, Gerald
Kateete, Patrick David
Nsangi, Olga Tendo
Kabahita, Jupiter Marina
Ssentalo Bagaya, Bernard
Golparian, Daniel
Unemo, Magnus
author_facet Kakooza, Francis
Kiggundu, Reuben
Mboowa, Gerald
Kateete, Patrick David
Nsangi, Olga Tendo
Kabahita, Jupiter Marina
Ssentalo Bagaya, Bernard
Golparian, Daniel
Unemo, Magnus
author_sort Kakooza, Francis
collection PubMed
description Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (NG), compromising gonorrhea treatment, is a global public health concern. Improved, quality-assured NG AMR monitoring at the global level is essential. This mini-review examined NG AMR susceptibility surveillance and AMR data from the African continent from 2001 to 2020. Eligible peer-reviewed publications (n = 30) containing NG AMR data for antimicrobials currently recommended for gonorrhea treatment were included. Overall, very limited NG surveillance and AMR data was available. Furthermore, the NG AMR surveillance studies varied greatly regarding surveillance protocols (e.g., populations and samples tested, sample size, antimicrobials examined), methodologies (e.g., antimicrobial susceptibility testing method [agar dilution, minimum inhibitory concentration (MIC) gradient strip test, disc diffusion test] and interpretative criteria), and quality assurance (internal quality controls, external quality assessments [EQA], and verification of AMR detected). Moreover, most studies examined a suboptimal number of NG isolates, i.e., less than the WHO Global Gonococcal Antimicrobial Surveillance Program (GASP) and WHO Enhanced GASP (EGASP) recommendations of ≥100 isolates per setting and year. The notable inter-study variability and frequently small sample sizes make appropriate inter-study and inter-country comparisons of AMR data difficult. In conclusion, it is imperative to establish an enhanced, standardized and quality-assured NG AMR surveillance, ideally including patient metadata and genome sequencing as in WHO EGASP, in Africa, the region with the highest gonorrhea incidence globally. This will enable the monitoring of AMR trends, detection of emerging AMR, and timely refinements of national and international gonorrhea treatment guidelines. To achieve this aim, national and international leadership, political and financial commitments are imperative.
format Online
Article
Text
id pubmed-10117771
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-101177712023-04-21 Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review Kakooza, Francis Kiggundu, Reuben Mboowa, Gerald Kateete, Patrick David Nsangi, Olga Tendo Kabahita, Jupiter Marina Ssentalo Bagaya, Bernard Golparian, Daniel Unemo, Magnus Front Microbiol Microbiology Antimicrobial resistance (AMR) in Neisseria gonorrhoeae (NG), compromising gonorrhea treatment, is a global public health concern. Improved, quality-assured NG AMR monitoring at the global level is essential. This mini-review examined NG AMR susceptibility surveillance and AMR data from the African continent from 2001 to 2020. Eligible peer-reviewed publications (n = 30) containing NG AMR data for antimicrobials currently recommended for gonorrhea treatment were included. Overall, very limited NG surveillance and AMR data was available. Furthermore, the NG AMR surveillance studies varied greatly regarding surveillance protocols (e.g., populations and samples tested, sample size, antimicrobials examined), methodologies (e.g., antimicrobial susceptibility testing method [agar dilution, minimum inhibitory concentration (MIC) gradient strip test, disc diffusion test] and interpretative criteria), and quality assurance (internal quality controls, external quality assessments [EQA], and verification of AMR detected). Moreover, most studies examined a suboptimal number of NG isolates, i.e., less than the WHO Global Gonococcal Antimicrobial Surveillance Program (GASP) and WHO Enhanced GASP (EGASP) recommendations of ≥100 isolates per setting and year. The notable inter-study variability and frequently small sample sizes make appropriate inter-study and inter-country comparisons of AMR data difficult. In conclusion, it is imperative to establish an enhanced, standardized and quality-assured NG AMR surveillance, ideally including patient metadata and genome sequencing as in WHO EGASP, in Africa, the region with the highest gonorrhea incidence globally. This will enable the monitoring of AMR trends, detection of emerging AMR, and timely refinements of national and international gonorrhea treatment guidelines. To achieve this aim, national and international leadership, political and financial commitments are imperative. Frontiers Media S.A. 2023-04-06 /pmc/articles/PMC10117771/ /pubmed/37089569 http://dx.doi.org/10.3389/fmicb.2023.1148817 Text en Copyright © 2023 Kakooza, Kiggundu, Mboowa, Kateete, Nsangi, Kabahita, Ssentalo Bagaya, Golparian and Unemo. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Kakooza, Francis
Kiggundu, Reuben
Mboowa, Gerald
Kateete, Patrick David
Nsangi, Olga Tendo
Kabahita, Jupiter Marina
Ssentalo Bagaya, Bernard
Golparian, Daniel
Unemo, Magnus
Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review
title Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review
title_full Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review
title_fullStr Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review
title_full_unstemmed Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review
title_short Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review
title_sort antimicrobial susceptibility surveillance and antimicrobial resistance in neisseria gonorrhoeae in africa from 2001 to 2020: a mini-review
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117771/
https://www.ncbi.nlm.nih.gov/pubmed/37089569
http://dx.doi.org/10.3389/fmicb.2023.1148817
work_keys_str_mv AT kakoozafrancis antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT kiggundureuben antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT mboowagerald antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT kateetepatrickdavid antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT nsangiolgatendo antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT kabahitajupitermarina antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT ssentalobagayabernard antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT golpariandaniel antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview
AT unemomagnus antimicrobialsusceptibilitysurveillanceandantimicrobialresistanceinneisseriagonorrhoeaeinafricafrom2001to2020aminireview